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1. Introduction 
The design of dynamic kinetic resolutions (DKRs) is an 
attractive manner to afford enantiopure compounds in 
theoretically 100% yield starting from racemates.1 These 
processes usually require the proper combination of a desired 
transformation with the in situ racemization of the slow-reacting 
enantiomer, so the action of mainly chiral auxiliaries, 
organocatalysts and metal-catalysis has been widely explored in 
recent decades.2 Biocatalytic transformations have gained 
increasing attention in the development of sustainable DKR 
processes due to the compatibility of chemical and enzymatic 
catalysts for selected reactions,3 enabling the asymmetrization of 
racemic alcohols, amines and carboxylic acid derivatives using 
mainly hydrolases as biocatalysts.2,4 More recently, the use of 
other classes of enzymes such as alcohol dehydrogenases5 and 
transaminases have opened a myriad of opportunities in the 
development of efficient DKR processes.6 
The design of enzyme-catalyzed DKRs under spontaneous 
conditions is especially attractive as simplifies the overall process 
without requiring the addition of external catalyst (i.e. bases, 
metal-complexes, auxiliaries, etc).7 This fact facilitates not only 
the optimization of the enzymatic process but also the isolation of 
the aimed optically active compound, avoiding undesired 
epimerization processes in some cases. Without any doubt, the 
presence of labile hydrogen atoms in the structural core of the 
racemate determines the possible application of this 
methodology. For instance, our group has recently reported the 
DKR of 1,3-dihydro-2H-isoindole-1-carboxylic acid methyl ester 
taking advantage of a deprotonation-protonation process of the 
achiral intermediate, which occurs under Pseudomonas cepacia 
lipase-catalyzed alkoxycarbonylation conditions (Figure 1 left).8 
Among biologically active compounds, -aminophosphonic 
acids have attracted a special interest in the latest decades.9 These 
analogues of -amino acids possess a phosphonic acid group 
rather than the carboxylic acid functionality. As a result, -
aminophosphonic acids and peptides incorporating them exhibit a 
broad range of biological and pharmacological activities.10 The 
outstanding properties of -aminophosphonic acids and 
phosphonates have stimulated the development of synthetic 
strategies towards the preparation of these compounds,11 being of 
special interest those leading to optically active compounds. 
Herein we wish to explore the enzyme-catalyzed resolution of 
the phosphonic counterpart of 1,3-dihydro-2H-isoindole-1-
carboxylic acid methyl ester, this is dimethyl (1,3-dihydro-2H-
isoindol-1-yl)phosphonate (Figure 1 middle), a phosphoproline 
analogue which is present in the structure of selective irreversible 
inhibitors of dipeptidyl peptidases 8 (DPP8) and 9 (DPP9).12 To 
the best of our knowledge, the biocatalyzed resolution of cyclic 
-aminophosphonic acid derivatives has been only reported in 
the lipase-catalyzed alkoxycarbonylation of dimethyl pyrrolidine-
2-phosphonate (Figure 1 right), finding moderate selectivity 
values after an exhaustive enzymatic study.13 
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occurs under mild reaction conditions. 









Figure 1. Structure of 1,3-dihydro-2H-isoindole-1-carboxylic acid methyl 
ester, dimethyl (1,3-dihydro-2H-isoindol-1-yl)phosphonate and dimethyl 
pyrrolidine-2-phosphonate. 
2. Results and discussion 
The synthesis of racemic dimethyl (1,3-dihydro-2H-isoindol-
1-yl)phosphonate (2) was performed starting from commercially 
available phthalimide. This procedure involves a three-step 
sequence towards the N-Boc protected precursor 1,14 which was 
deprotected under acidic conditions in 90% yield (Scheme 1). 
Prior to develop enzymatic transformations, the allyl and benzyl 
racemic carbamates 4a-b were prepared using allyl chloroformate 
(3a) or benzyl chloroformate (3b) in 70% and 99% isolated yield 
respectively. These racemates were only used for analytical 
purposes in the development of reliable chiral methods for the 
measurement of the enantiomeric excess values once the 
biocatalyzed products were obtained. 
 
Scheme 1. Chemical synthesis of racemic dimethyl (1,3-dihydro-2H-
isoindol-1-yl)phosphonate and related allyl and benzyl carbamates 4a,b. 
Based on the excellent results found in the resolution of 1,3-
dihydro-2H-isoindole-1-carboxylic acid methyl ester,8 the 
resolution of aminophosphonate 2 was attempted through an 
alkoxycarbonylation reaction using a series of lipases that 
includes Pseudomonas cepacia lipase (PSL-C I), Candida 
antarctica lipase type B (CAL-B) and Candida antarctica lipase 
type A (CAL-A). The enzymatic screening was conducted at a 
140 mM substrate concentration in tert-butyl methyl ether 
(MTBE) at 30 ºC (Table 1), initially using commercially 
available diallyl carbonate (5a). In contrast with the excellent 
activity displayed towards the carbamoylation of 1,3-dihydro-
2H-isoindole-1-carboxylic acid methyl ester,8 PSL-C I did not 
display any activity against the homologue phosphonate 2 (entry 
1). Similarly, the racemic starting material was recovered 
untouched in the reaction with CAL-B (entry 2). Satisfyingly, 
CAL-A catalyzed the formation of (R)-4a in 78% ee and 50% 
conversion after 92 h (entry 3), obtaining the remaining 
aminophosphonate (S)-2 in 26% ee. This poor optical purity of 
the substrate at a considerable conversion value suggests its 
racemization in the reaction medium, so the possibility of 
achieving a suitable DKR process was opened at this time. We 
propose a deprotonation-protonation equilibrium through an 
achiral enolate intermediate, as occurs with its 1,3-dihydro-2H-
isoindole-1-carboxylic acid methyl ester analogue.8 
Then, the enzymatic study was continued employing a series 
of carbonates, such as commercially available dibenzyl carbonate 
(5b) and easily to prepare allyl 3-methoxyphenyl carbonate (5c)15 
in combination with CAL-A. On the one hand, the dibenzyl 
carbonate was used although no conversion was observed (entry 
4). On the other hand, high conversions and selectivities were 
observed with the more reactive allyl 3-methoxyphenyl carbonate 
5c (entries 5 and 6), obtaining the (R)-allyl carbamate 4a in 58% 
isolated yield and 96% ee after column chromatography, while 
the substrate was recovered almost in racemic form when the 
reaction was carried out in toluene as solvent. It must be noticed 
that the optical purity of the amino phosphonate decreased at 
prolonged times under air conditions, demonstrating the lability 
of the hydrogen atom in the -position to the phosphonate group. 
In all cases, the remaining amino phosphonate 2 and the 
corresponding carbamate were found as unique products in the 
biotransformation, although a side hydrolysis reaction or 
decomposition are not discarded during the purification step 
using a column chromatography on silica gel. 
  
Table 1. Asymmetric alkoxycarbonylation of racemic aminophosphonate 2 using different lipases (ratio 2:1 lipase:substrate w/w) 
and 2.5 equiv. of alkyl carbonates at 30 ºC and 250 rpm. 
 
Entry Lipase Solvent Carbonate 5a-c t (h) c (%)a eeP (%)
b eeS (%)
b 
1 PSL-C I MTBE 5a 24 <1 ---- ---- 
2 CAL-B MTBE 5a 48 <1 ---- ---- 
3 CAL-A MTBE 5a 92 50 78 26 
4 CAL-A MTBE 5b 24 <1 ---- ---- 
5 CAL-A MTBE 5c 27 67 87 32 
6 CAL-A Toluene 5c 47 77 96 (58) 9 
a Conversion values determined by 1H-NMR of the reaction crudes. Isolated yields in parentheses. 
b Enantiomeric excess values determined by HPLC analysis. 
 
 3 
Table 2. Dynamic kinetic resolution of racemic aminophosphonate 2 using CAL-A and allyl 3-methoxyphenyl carbonate in 
toluene at 250 rpm. 
 
Entry CAL-Aa 5c (equiv.) (±)-2 (mM) T (ºC) t (h) c (%)b eeP (%)c 
1 2:1 2.5 140 30 47 77 96 
2 4:1 2.5 140 30 46 62 95 
3 2:1 2.5 140 45 47 68 94 
4 2:1 2.5 280 30 46 59 91 
5 2:1 10 140 30 71 57 85 
a Ratio CAL-A:aminophosphonate (w/w). 
b Conversion values determined by 1H-NMR of the reaction crudes. 
b Enantiomeric excess values determined by HPLC analysis. 
 
Exploring other reaction conditions for the asymmetric 
synthesis of the allyl carbamate (R)-4a, a series of reaction 
parameters were considered such as an increase in enzyme and 
carbonate 5c loadings, and the use of higher substrate 
concentrations and temperatures (Table 2). Doubling the amount 
of enzyme did not affect significantly the reaction, observing a 
slight reduction of the conversion but maintaining the selectivity 
(entries 1 and 2), while the use of higher temperatures did not 
significantly affect the final results (entry 3). A higher substrate 
concentration (280 mM) did not lead to a beneficial impact either 
in the kinetic or the selectivity of the process (entry 4). Finally, 
the DKR was attempted with a significant excess of the carbonate 
5c but the enantiomeric excess of the carbamate and the 
conversion were considerably lower even at prolonged reaction 
times (entry 5). 
Absolute configuration of the allyl carbamate 4a resulting 
from the resolution catalyzed by CAL-A at 30 ºC (entry 6, Table 
1) was determined by 1H-NMR analyses. The synthesis of the 
corresponding Mosher amide derivative 6 was required, firstly 
starting from racemic 2 and later using the allyl carbamate 4a 
obtained in 96% ee under enzyme-catalyzed DKR conditions 
(Scheme 2). Derivatization of the free aminophosphonate (±)-2 
was performed employing the (S)-(+)--methoxy--
(trifluoromethyl)phenylacetyl chloride (MTPA-Cl) in the 
presence of triethylamine. Firstly, the mixture of 
diastereoisomeric Mosher amides (RS,R)-6 was prepared 
(Scheme 2 top), clearly finding two doblet signals in the 1H-
NMR spectrum at 5.87 ppm (2JPH = 9.0 Hz) and 5.99 ppm (
2JPH = 
8.9 Hz) corresponding to the CH in α position to the nitrogen 
atom (Figure 2). The doblet signal at higher fields corresponds to 
the (R,R)-6 due to the magnetic anisotropy caused by the phenyl 
ring, while at lower fields the (S,R)-6 diastereoisomer was found 
with the hydrogen atom and the phenyl ring at opposite sides. 
Secondly, the allyloxycarbonyl group of 4a obtained in the 
lipase-catalyzed alkoxycarbonylation was deprotected by reaction 
with 1,3-dimethylbarbituric acid (DMBA), palladium (II) acetate 
and triphenylphosphine (Scheme 2 bottom). Thus, the 
corresponding free aminophosphonate 2 was isolated and 
immediately derivatized using (S)-MTPA-Cl in the presence of 
triethylamine to afford the desired optically active Mosher amide 
6 in good yield. 
Comparison of the 1H-NMR spectra of the diastereoisomeric 
mixture of Mosher amides and the corresponding to the Mosher 
derivative of the optically active product (Figure 3), allowed us 
to define (R)-configuration for the chiral center in the isoindoline 
core, and then a (R,R)-stereochemistry for the Mosher amide 6. 
Partial epimerization was observed after the deprotection-
derivatization sequence (91% diastereomeric excess from a 
starting 96% enantiomeric excess), highlighting the lability of 
this type of compound, although the racemization occurs in a 
little extent in comparison with the homologue methyl ester.8 
 
Figure 2. 1H-NMR spectrum window with representative signals for the 
mixture of diastereoisomeric Mosher amides (RS,R)-6. For simplicity P 




Scheme 2. Synthesis of Mosher amide derivatives for the determination of the absolute configurations of allyl carbamate 4a obtained in the biocatalyzed DKR 
using CAL-A. 
 
Figure 3. 1H-NMR spectrum window with representative signals for the 
Mosher amide derivative (R,R)-6 isolated in 91% de. For simplicity P 
represents the dimethyl phosphonate functionality. 
3. Conclusion 
Lipase-catalyzed transformations have been studied for the 
resolution of dimethyl (1,3-dihydro-2H-isoindol-1-
yl)phosphonate. The approach was based on the 
alkoxycarbonylation reaction of the free amino group, developing 
a dynamic kinetic resolution process motivated by the in situ 
racemization of the slower reacting enantiomer in the biocatalytic 
process in the absence of auxiliaries. The combination of 
Candida antarctica lipase type A and allyl 3-methoxyphenyl 
carbonate using toluene as solvent under mild reaction conditions 
led to the recovery of the (R)-allyl carbamate in 58% isolated 
yield and 96% enantiomeric excess. A series of reaction 
parameters were studied searching for a global knowledge of the 
biocatalyzed transformation, although in all cases conversions 
were up to 77% generally obtaining high selectivities. 1H-NMR 
analyses served for the assignment of the absolute configuration 
of the resulting (R)-allyl carbamate, after its convenient 
transformation into the corresponding Mosher amide derivative. 
4. Experimental 
4.1. General 
Pseudomonas cepacia lipase type I immobilized over a 
ceramic support (PSL-C I, Amano, 1019 U/g), was purchased 
from Sigma-Aldrich. Candida antarctica lipase type B (CAL-B, 
Novozyme 435, 7300 PLU/g) was a gift from Novozymes 
(Denmark). Candida antarctica lipase A (CAL-A, 2.6 U/mg 
solid) was purchased from Codexis.  
All other reagents and solvents were used as received from 
commercial suppliers without further purification. Column 
chromatographies were performed using silica gel 60 (230-240 
mesh) purchased from Merck. Melting points were measured in a 
Gallenkamp apparatus, and taken on samples in open capillary 
tubes. IR spectra were recorded on a Varian 1000 FT-IR 
spectrometer using NaCl plates or KBr pellets. 1H, 13C and DEPT 
NMR experiments were performed using AV-300 and DPX-300 
Brüker spectrometers at room temperature (1H, 300.13 MHz and 
13C, 75.5 MHz). The chemical shifts are given in delta () values 
and the coupling constants (J) in Hertz (Hz). High-resolution 
mass spectra were recorded on a Bruker Microtof-Q 
spectrometer. Enantiomeric excess values were determined 
through HPLC analyses using an Agilent 1100 Series 
chromatogram with a 20% of 2-propanol/hexane as eluent with a 
0.8 mL/min flow at 30 ºC. A Chiralcel OJ-H (25 x 4.6 mm i.d.) 
column was used for the allyl carbamate 4a 8.0 minutes for the 
(R)-enantiomer and 9.7 minutes for the (S)-enantiomer and for 
the benzyl carbamate 4b (14.7 and 23.8 minutes), while a 
Chiralpak AS (25 x 4.6 mm i.d.) column was used for the free 
aminophosphonate 2 13.1 minutes for the (R)-enantiomer and 
19.1 minutes for the (S)-enantiomer. 
4.2. Synthesis of dimethyl (1,3-dihydro-2H-isoindol-1-
yl)phosphonate, 2 
A suspension of N-Boc protected aminophosphonate 1 (200 
mg, 0.61 mmol) in an aqueous HCl 3 M solution (10 mL) was 
stirred at room temperature for 6 h until complete solubility of 
the mixture. The solution was basified with an aqueous NaOH 4 
M solution (10 mL) and extracted with CH2Cl2 (3 x 15 mL). The 
organic phases were combined, dried over Na2SO4, filtered and 
the solvent was evaporated under reduced pressure, yielding the 
racemic and free-protected aminophosphonate 2 as a colourless 
viscous liquid (90%). Rf (70% EtOAc/hexane): 0.24. IR (NaCl)  
3417, 1594, 1230, 1034 cm-1. 1H-NMR (CDCl3, 300.13 MHz)  
3.58 (d, 3JPH= 10.3 Hz, 3H, OMe), 3.75 (d, 
3JPH= 10.4 Hz, 3H, 
OMe), 4.23-4.44 (m, 2H, H3), 4.78 (d, 
2JPH = 7.7 Hz, 1H, H1), 
5.26 (brs, 1H, NH), 7.19-7.29 (m, 3H, Ar), 7.46 (dd, 3JHH = 5.2,
 
4JHH = 1.8 Hz, 1H, Ar) ppm. 
13C-NMR (CDCl3, 75.5 MHz)  52.5 
(d, 3JPC = 2.4 Hz, CH2, C3), 53.2 (d, 
2JPC = 7.3 Hz, CH3, OMe), 
53.6 (d, 2JPC = 7.2 Hz, CH3, OMe), 60.6 (d, 
1JPC = 159.3 Hz, CH, 
C1), 122.6 (d, JPC = 2.2 Hz, CH, Ar), 123.9 (d, JPC = 3.3 Hz, CH, 
Ar), 127.1 (d, JPC = 2.9 Hz, CH, Ar), 128.0 (d, JPC = 3.0 Hz, CH, 
Ar), 136.3 (d, 3JPC = 3.9 Hz, C, C3a), 141.7 (d, 
2JPC = 7.2 Hz, C, 
 5 
C7a) ppm. HRMS (ESI
+, m/z) calcd for C10H14NNaO3P
+ 
(M+Na)+: 250.0604, found: 250.0606. 
4.3. Synthesis of dimethyl [N-(allyloxycarbonyl)-1,3-dihydro-
2H-isoindol-1-yl]phosphonate, 4a 
Pyridine (23.5 µL, 0.29 mmol, 1.11 equiv.) and allyl 
chloroformate (3a, 30.8 µL, 0.29 mmol, 1.11 equiv.) were 
successively added to a solution of racemic aminophosphonate 2 
(60 mg, 0.26 mmol) in dry dichloromethane (1 mL) and under 
inert atmosphere. The solution was stirred at room temperature 
for 2 h, and after this time the solvent was evaporated under 
reduced pressure. The reaction crude was purified through 
column chromatography on silica gel (80% EtOAc/hexane as 
eluent), yielding the racemic carbamate 4a as a white solid (70% 
isolated yield). Rf (80% EtOAc/hexane): 0.30. Mp: 74-76 ºC. 
1H-
NMR (CDCl3, 300.13 MHz) δ (dupplicated signals are observed 
for some protons and they have been shown in brackets; asterisks 
indicate those ones corresponding to the minor rotamer) [3.45* 
(d, 3JPH = 10.4 Hz) + 3.52 (d, 
3JPH = 10.5 Hz, 3H, OMe)], [3.77* 
(d, 3JPH = 10.7 Hz) + 3.85 (d, 
3JPH = 10.7 Hz, 3H, OMe)], 4.59-
4.63 (m, 3H, H3 + H1’), 5.24 (d, 
2JHH = 10.4 Hz, 1H, H3’), 5.36 
(dd, 2JHH = 10.4 Hz, 
3JHH = 17.1 Hz, 1H, H3’), [5.50* (d, 
2JPH = 
6.4 Hz) + 5.54 (d, 2JPH = 6.6 Hz, 1H, H1)], 5.97 (ddt, 
3JHH = 16.4, 
10.6, 5.5 Hz, 1H, H2’), 7.26-7.35 (m, 3H, Ar), 7.45-7.56 (m, 1H, 
Ar) ppm. 13C-NMR (CDCl3, 75.5 MHz)  (dupplicated signals 
are observed for most of the carbon atoms and they have been 
shown in brackets; asterisks indicate those ones corresponding to 
the minor rotamer; doblet signals for the methoxy rotamers 
appears overlapped) [52.5 + 52.8* (CH2, C3)], 53.5-53.7 (m, 
2CH3, OMe), 59.8 (d, 
1JPC = 158.8 Hz, CH, C1), [66.6 + 66.8* 
(CH2, C1’)], [117.9 + 118.3* (CH2, C3’)], [122.6 + 122.7* (CH, 
Ar)], 124.3 (CH, Ar), 127.7 (CH, Ar), 128.5 (CH, Ar), 132.7 
(CH, C2’), 134.1 (C, Ar), 137.9 (C, Ar), 154.7 (C, C=O) ppm. 
HRMS (ESI+, m/z) calcd for C15H22NNaO5P
 + (M+Na)+: 
334.0815, found: 334.0825. 
4.4. Synthesis of dimethyl [N-(benzyloxycarbonyl)-1,3-
dihydro-2H-isoindol-1-yl]phosphonate, 4b 
Pyridine (23.5 µL, 0.29 mmol, 1.11 equiv.) and benzyl 
chloroformate (3b, 41.4 µL, 0.29 mmol, 1.11 equiv.) were 
successively added to a solution of racemic aminophosphonate 2 
(60 mg, 0.26 mmol) in dry dichloromethane (1 mL) and under 
inert atmosphere. The solution was stirred at room temperature 
for 2 h, and after this time the solvent was evaporated under 
reduced pressure. The reaction crude was purified through 
column chromatography on silica gel (80% EtOAc/hexane), 
yielding the carbamate 4b as a light yellow liquid (99% isolated 
yield). Rf (100% EtOAc): 0.49. IR (NaCl): 1707, 1411, 1359, 
1282, 1031 cm-1. 1H-NMR (CDCl3, 300.13 MHz) δ (dupplicated 
signals are observed for some protons and they have been shown 
in brackets; asterisks indicate those corresponding to the minor 
rotamer) [3.38* (d, 3JPH = 10.4 Hz) + 3.51 (d, 
3JPH = 10.4 Hz, 3H, 
OMe)], [3.57* (d, 3JPH = 10.7 Hz) + 3.84 (d, 
3JPH = 10.7 Hz, 3H, 
OMe)], 4.59-4.74 (m, 1H, H3), 4.87-5.07 (m, 1H, H3), 5.14-5.29 
(m, 2H, Cbz), [5.49* (d, 2JPH = 6.5 Hz) + 5.56 (d, 
2JPH = 5.9 Hz, 
1H, H1)], 7.19-7.54 (m, 9H, Ar) ppm. 
13C-NMR (CDCl3, 75.5 
MHz)  (dupplicated signals are observed for most of the carbon 
atoms and they have been shown in brackets; asterisks indicate 
those ones corresponding to the minor rotamer) δ [52.5 + 52.8* 
(CH2, C3)], [53.3* (d, 
2JPC = 6.7 Hz), 53.6 (d, 
2JPC = 4.3 Hz, CH3, 
OMe),], 53.6-53.8 (m, CH3, OMe), 59.8 (d, 
1JPC = 158.8 Hz, CH, 
C1), [67.6 + 67.9* (CH2, Cbz)], [122.5 (d, JPC = 3.0 Hz) + 122.6* 
(d, JPC = 3.1 Hz, CH, Ar)], [124.2* (d, JPC = 3.1 Hz) + 124.3 (d, 
JPC = 3.4 Hz, CH, Ar)], 127.6-127.8 (m, CH, Ar), 128.1 (CH, 
Ar), 128.3 (CH, Ar), 128.3-128.5 (m, CH, Ar), 128.6 (4CH, 
Cbz), [133.8 (d, JPC = 4.0 Hz), 134.0* (d, JPC = 3.5 Hz, C, Ar)], 
[136.2*, 136.4 (C, Cbz)], [137.7* (d, JPC = 5.4 Hz), 137.8 (d, 
JPC = 5.7 Hz, C, Ar)], [154.7*, 154.8 (C, C=O)] ppm. HRMS 
(ESI+, m/z) calcd for C18H20NNaO5P
+ (M+Na)+: 384.0971, found: 
384.0976. 
4.5. General procedure for the lipase-catalyzed dynamic 
resolution of dimethyl (1,3-dihydro-2H-isoindol-1-
yl)phosphonate, 2 
An erlenmeyer flask containing the racemic 
aminophosphonate 2 (100 mg, 0.44 mmol), the allyl 3-
methoxyphenyl carbonate (5c, 228 mg, 1.10 mmol, 2.5 equiv.) 
and CAL-A (200 mg, 2:1 in weight respect to the substrate) was 
stopped with a septum and an inert atmosphere was generated 
with the aid of a needle. Dry toluene (3.1 mL) was added and the 
reaction mixture was shaken at 30 ºC and 250 rpm for 47 h. The 
enzyme was removed by filtration, washed with CH2Cl2 (3 x 5 
mL), and the solvents removed under reduce pressure to reach a 
77% conversion value (1H-NMR of the reaction crude). The so-
obtained reaction crude was purified by column chromatography 
on silica gel to obtain the carbamate (R)-4a (58% isolated yield, 
96% ee) using a 80% EtOAc/hexane eluent, and the remaining 
amiophosphonate (S)-2 (9% ee) when eluting with a 100% 
EtOAc eluent. 20D –58.3 (c 0.3, EtOH) for 96% ee. 
4.6. General procedure for the synthesis of the Mosher 
derivative (RS,R)-6 
The (S)-Mosher’s acid chloride (10 µL, 0.055 mmol, 1.25 
equiv.) and dry Et3N (8 µL, 0.055 mmol, 1.25 equiv.) were 
successively added to a solution of racemic aminophosphonate 2 
(10 mg, 0.044 mmol) in dry CH2Cl2 (0.5 mL) under inert 
atmosphere. The mixture was stirred for 10 h at room 
temperature and then CH2Cl2 (10 mL) was added. The solution 
washed with H2O (2 x 10 mL), dried with Na2SO4, filtered and 
concentrated under reduced pressure. The resulting residue was 
analyzed by 1H-NMR in order to identify characteristic signals 
for diastereoisomers (R,R)-6 and (S,R)-6. 
4.7. General procedure for the deprotection of the 
allyloxycarbonyl group of (R)-dimethyl [N-
(allyloxycarbonyl)-1,3-dihydro-2H-isoindol-yl]phosphonate, 
4a 
N,N-Dimethylbarbituric acid (27 mg, 0.17 mmol, 2.7 equiv.), 
Pd(OAc)2 (1.5 mg, 0.0064 mmol, 0.10 equiv.) and PPh3 (5.0 mg, 
0.019 mmol, 0.30 equiv.) were successively added to a solution 
of optically active carbamate (R)-4a (20 mg, 0.064 mmol, 96% 
ee) in dry CH2Cl2 (0.8 mL) under inert atmosphere. The mixture 
was stirred at reflux temperature during 1 h, and then it was 
slowly cooled until room temperature. Additional CH2Cl2 (10 
mL) was added to the solution, which was washed with water (2 
x 10 mL). The organic layer was dried with Na2SO4, filtered and 
concentrated under reduced pressure, yielding a reaction crude 
that mainly contains the free aminophosphonate (R)-2. A further 
purification of this reaction crude was discarded to avoid a 
possible racemization of the product. 
4.8. General procedure for the synthesis of the Mosher 
derivative (R,R)-6 
To a solution of the so-obtained residue from the removal of 
the allyloxycarbonyl group reaction (0.064 mmol for a 
theoretically 100% yield) in dry CH2Cl2 (0.7 mL) and under inert 
atmosphere, the (S)-Mosher’s acid chloride (15 µL, 0.080 mmol, 
1.25 equiv.) and dry Et3N (11 µL, 0.080 mmol, 1.25 equiv.) were 
successively added. The mixture was stirred for 10 h at room 
temperature and then CH2Cl2 (10 mL) was added. The solution 
was washed with H2O (2 x 10 mL), dried with Na2SO4, filtered 
Tetrahedron 6 
and concentrated under reduced pressure. The resulting residue 
was purified by column chromatography on silica gel (50% 
EtOAc/hexane), yielding the corresponding Mosher derivative 
(R,R)-6 with 91% de (76% isolated yield). 
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